menu
    • menu

    Company profile for Indivior

    NEW Drugs in Dev: 15
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    The world leader in addiction treatment with over 20 years of experience and a patient-focused approach.We at Indivior are on an endeavor – one that is focused on individual patients around the world. Our name reflects this as the key words individual and endeavor harmoniously blend together. It represents and empathizes with the often difficult journey each individual patient takes to overcome the challenges of addiction �...
    The world leader in addiction treatment with over 20 years of experience and a patient-focused approach.We at Indivior are on an endeavor – one that is focused on individual patients around the world. Our name reflects this as the key words individual and endeavor harmoniously blend together. It represents and empathizes with the often difficult journey each individual patient takes to overcome the challenges of addiction – a chronic relapsing disease.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    IndiviorUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Indivior Inc.North Chesterfield, Virginia, USA
    Telephone
    Telephone
    +1 804 379 1090
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.indivior.com/en
    Linkedin
    Linkedin
    https://in.linkedin.com/company/indivior
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/indivior?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    BPI Europe

    BPI Europe

    Not Confirmed

    envelop Contact Supplier

    BPI Europe

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Indivior Presents Data Backing Buprenorphine Use for OUD at ASAM
    Indivior Presents Data Backing Buprenorphine Use for OUD at ASAM

    24 Apr 2026

    // FIRSTWORD PHARMA

    https://firstwordpharma.com/story/7206210

    FIRSTWORD PHARMA
    24 Apr 2026
    Share Share
    Indivior Reports Q1 2026 Results; Webcast on April 30
    Indivior Reports Q1 2026 Results; Webcast on April 30

    09 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/09/3270768/0/en/Indivior-to-Report-First-Quarter-2026-Financial-Results-and-Host-Webcast-on-April-30th.html

    GLOBENEWSWIRE
    09 Apr 2026
    Share Share
    Survey: 58% US Prisons Offer Opioid Use Disorder Drugs
    Survey: 58% US Prisons Offer Opioid Use Disorder Drugs

    17 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/17/3257476/0/en/National-Survey-Finds-Only-58-of-U-S-Correctional-Facilities-Offer-Medications-for-Opioid-Use-Disorder.html

    GLOBENEWSWIRE
    17 Mar 2026
    Share Share
    Indivior Announces Proposed Convertible Senior Notes Offering
    Indivior Announces Proposed Convertible Senior Notes Offering

    12 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/12/3254448/0/en/Indivior-Announces-Proposed-Convertible-Senior-Notes-Offering.html

    GLOBENEWSWIRE
    12 Mar 2026
    Share Share
    Monthly Injectable Buprenorphine Cuts Costs in Opioid Disorder
    Monthly Injectable Buprenorphine Cuts Costs in Opioid Disorder

    11 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/11/3253803/0/en/New-Study-Shows-Adherence-to-Monthly-Injectable-Buprenorphine-Linked-to-Lower-Healthcare-Utilization-and-Costs-in-Opioid-Use-Disorder.html

    GLOBENEWSWIRE
    11 Mar 2026
    Share Share
    Indivior Picks Havas To Lead US Marketing Efforts
    Indivior Picks Havas To Lead US Marketing Efforts

    24 Feb 2026

    // FIERCE PHARMA

    https://www.fiercepharma.com/marketing/indivior-picks-havas-lead-us-marketing-efforts-dtc-push-ramps

    FIERCE PHARMA
    24 Feb 2026
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact Indivior and get a quotation

    Indivior is a supplier offers 2 products (APIs, Excipients or Intermediates).

    Find Buprenorphine bulk offered by Indivior

    Find Buprenorphine Hydrochloride bulk offered by Indivior

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search